n.a. (HSP)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Cramer: Spinoffs Are in Vogue

The logic of owning the pure play is attractive.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Hospira, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Hospira, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against Hospira, Inc.

Stocks Hold Highs as Crude Oil Recovers $50 on Bets of Global Growth

Stocks Hold Highs as Crude Oil Recovers $50 on Bets of Global Growth

Stocks are buoyed by a rebound in crude oil prices and a rally in health care stocks.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Hospira Inc. Regarding The Fairness Of The Sale Of The Company To Pfizer

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Launches An Investigation Of The Board Of Directors Of Hospira Inc. Regarding The Fairness Of The Sale Of The Company To Pfizer

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Hospira Inc.

Pfizer's Bid for Hospira Cheered by Investors: What Wall Street's Saying

Pfizer's Bid for Hospira Cheered by Investors: What Wall Street's Saying

Wall Street cheers Pfizer's plan to acquire Hospira to the tune of $17 billion on Thursday. Here is the initial take from analysts.

Pfizer to Acquire Hospira

$17 billion cash deal broadens product line; no trades recommended

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Hospira, Inc. Concerning Its Proposed Sale To Pfizer Inc. - HSP

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Hospira, Inc. Concerning Its Proposed Sale To Pfizer Inc. - HSP

The Rosen Law Firm announces that it is investigating the Board of Directors of Hospira, Inc.

HOSPIRA INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Pfizer Inc.

HOSPIRA INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Pfizer Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Hospira Inc.

Stocks Extend Highs After Crude Oil Again Pushes Above $50

Stocks Extend Highs After Crude Oil Again Pushes Above $50

Stocks rise Thursday, recapturing some of the upward momentum enjoyed earlier in the week.

INVESTOR ALERT: Levi & Korsinsky, LLP Commences An Investigation Of The Board Of Directors Of Hospira Inc. In Connection With The Fairness Of The Sale Of The Company To Pfizer

INVESTOR ALERT: Levi & Korsinsky, LLP Commences An Investigation Of The Board Of Directors Of Hospira Inc. In Connection With The Fairness Of The Sale Of The Company To Pfizer

Levi & Korsinsky is commencing an investigation into the Board of Directors of Hospira Inc.

Hospira, Inc. (HSP) Snapped Up By Pfizer For $17 Billion

Hospira, Inc. (HSP) Snapped Up By Pfizer For $17 Billion

Merger mania continues in the pharmaceutical industry. Pharma giant Pfizer announced on Thursday, February 5th that it has come to an agreement to acquire leading injectable drug and biosimilars produ...

Hospira (HSP) Stock Spikes Today on $17 Billion Pfizer Merger

Hospira (HSP) Stock Spikes Today on $17 Billion Pfizer Merger

Hospira (HSP) shares are up double digits in pre-market trading after being purchased by Pfizer (PFE) for $17 billion today.

Pfizer Gets Growth Injection With $17 Billion Hospira Deal

Pfizer Gets Growth Injection With $17 Billion Hospira Deal

The New York-based buyer has been seeking new targets since an unsuccessful $120 billion bid for AstraZeneca.

Stock Futures Hold Gains as Jobless Claims Lower Than Forecast

Stock Futures Hold Gains as Jobless Claims Lower Than Forecast

Stock futures signal a small rebound on Thursday.

Today's Pre-Market Mover With Heavy Volume: Hospira (HSP)

Today's Pre-Market Mover With Heavy Volume: Hospira (HSP)

Trade-Ideas LLC identified Hospira (HSP) as a pre-market mover with heavy volume candidate

February 5 Premarket Briefing: 10 Things You Should Know

February 5 Premarket Briefing: 10 Things You Should Know

U.S. stock futures rise slightly after the ECB's ban on Greek bonds; Twitter to report earnings; health insurer Anthem says its network was hacked; Pfizer to buy Hospira.

Pfizer To Acquire Hospira

Pfizer To Acquire Hospira

Pfizer Inc. (NYSE:PFE) and Hospira, Inc.

Insider Trading Alert - VICL, TIPT And HSP Traded By Insiders

Insider Trading Alert - VICL, TIPT And HSP Traded By Insiders

Stocks with insider trader activity include VICL, TIPT and HSP

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Shire has cash for what could be a $5 billion deal, but treatment base is limited.

Today's Strong And Under The Radar Stock: Hospira (HSP)

Today's Strong And Under The Radar Stock: Hospira (HSP)

Trade-Ideas LLC identified Hospira (HSP) as a strong and under the radar candidate

Merck May Have Paid $2B-$3B Too Much For Cubist, Analyst Says

Merck May Have Paid $2B-$3B Too Much For Cubist, Analyst Says

Shares of Merck are tumbling after a Delaware court denied Cubist's bid to stop Hospira from selling a generic version of Cubicin in 2016.

Trade-Ideas: Hospira (HSP) Is Today's Post-Market Leader Stock

Trade-Ideas: Hospira (HSP) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Hospira (HSP) as a post-market leader candidate

Jim Cramer on the Stock Market: Here Are 12 Sectors to Bet On

Jim Cramer on the Stock Market: Here Are 12 Sectors to Bet On

A look at the sectors and top stocks in each

The New #33 Most Shorted S&P 500 Component: Hospira

The New #33 Most Shorted S&P 500 Component: Hospira

The most recent short interest data has been released by the NASDAQ for the 09/30/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Hospira Becomes #124 Most Shorted S&P 500 Component, Replacing PACCAR

Hospira Becomes #124 Most Shorted S&P 500 Component, Replacing PACCAR

The most recent short interest data has been released by the NASDAQ for the 09/15/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Hospira (HSP) Is Today's Water-Logged And Getting Wetter Stock

Hospira (HSP) Is Today's Water-Logged And Getting Wetter Stock

Trade-Ideas LLC identified Hospira (HSP) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Hospira Becomes #99 Most Shorted S&P 500 Component, Replacing Fossil Group

Hospira Becomes #99 Most Shorted S&P 500 Component, Replacing Fossil Group

The most recent short interest data has been released by the NASDAQ for the 08/15/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Why Hospira (HSP) Stock Is Lower Today

Why Hospira (HSP) Stock Is Lower Today

The drug maker sued the FDA over its decision to pave the way for generic forms of Hospira's Precedex sedative.

July 29 Premarket Briefing: 10 Things You Should Know

July 29 Premarket Briefing: 10 Things You Should Know

U.S. stock futures looked optimistic Tuesday as investors prepped for a deluge of earnings and applauded Monday's merger news.

Why Hospira (HSP) Stock Is Surging Today

Why Hospira (HSP) Stock Is Surging Today

Shares of Hospira (HSP) are up after it was reported that Danone (DANOY) is in talks to sell its medical nutrition business to them in a deal worth $5 billion